John Stagg - Concepedia

Author

John Stagg

Centre Hospitalier de l’Université de Montréal ORCID

Also Known As

J Stagg, J. C. A. Stagg, J. Stagg, Jennifer Stagg, John C Stagg, John Stagg, Stagg, John

269

Publications

18.7K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier de l’Université de Montréal Université de Montréal Peter MacCallum Cancer Centre The University of Melbourne Institut Jules Bordet

About

John Stagg is an author at Centre Hospitalier de l’Université de Montréal specializing in medicine, immunology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	29	4.6K
2	Engineering	1	1	13
3	Natural Sciences	1	1	14
4	Allergy	1	1	37
5	Biochemistry	1	1	14

John Stagg

Publications

10.1K

Citations

H-Index

Page 1

	Year	Citations
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy Lukas F. Mager, Regula Burkhard, Nicola Pett, Science	2020	1.2K
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis John Stagg, Upulie Divisekera, Nicole M. McLaughlin, Proceedings of the National Academy of Sciences Tumor ImmunologyBreast OncologyCancer ImmunosurveillanceTumor GrowthImmunology	2010	561
Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient mice Nicoletta Eliopoulos, John Stagg, Laurence Lejeune, Blood	2005	552
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer Sherene Loi, Sandra Pommey, Benjamin Haibe‐Kains, Proceedings of the National Academy of Sciences Breast OncologyOncologyCancer ImmunosurveillanceMedicineImmunology	2013	478
Anti–ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti–PD-1 or anti-CD137 mAb therapy John Stagg, Sherene Loi, Upulie Divisekera, Proceedings of the National Academy of Sciences	2011	476
Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs Bertrand Allard, Sandra Pommey, Mark J. Smyth, Clinical Cancer Research	2013	442
Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers Tina Gruosso, Mathieu Gigoux, Venkata Manem, Journal of Clinical Investigation Breast OncologyImmunologyBiological MicroenvironmentsImmune Cell TherapyImmunotherapy	2019	406
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis John Stagg, Upulie Divisekera, Helene Duret, Cancer Research T-regulatory CellImmunoeditingImmunologyImmune RegulationRegulatory T Cells	2011	391
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death Abhishek D. Garg, Lorenzo Galluzzi, Lionel Apétoh, Frontiers in Immunology ApoptosisImmunologyCell DeathImmunologic MechanismAntigen Processing	2015	381
Blockade of A <sub>2A</sub> receptors potently suppresses the metastasis of CD73 <sup>+</sup> tumors Paul A. Beavis, Upulie Divisekera, Christophe Paget, Proceedings of the National Academy of Sciences ImmunologyImmune RegulationImmunoeditingImmunologic MechanismImmunotherapy	2013	334

Page 1